Literature DB >> 1955276

An open trial of nortriptyline in women with chronic pelvic pain.

E A Walker1, P P Roy-Byrne, W J Katon, R Jemelka.   

Abstract

Although antidepressants have been used in the management of several types of chronic pain there have been no systematic trials of these medications in women with chronic pelvic pain. The authors report on the use of nortriptyline in fourteen women with chronic pelvic pain. Seven women dropped out of the study. These seven subjects were significantly different from the treated group only in lower tolerance of antidepressant side effects. Six of the seven treated subjects reported complete or partial relief from pain. Fifty seven percent of the drop-outs and the one nonresponding treated subject had histories of childhood sexual abuse. This open trial suggests that antidepressants may be effective in the treatment of some women with chronic pelvic pain. However, the frequent association of sexual abuse with this disorder indicates that accepted treatment trial designs may need to be altered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955276     DOI: 10.2190/EXRP-J206-CBWT-UTFK

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  4 in total

Review 1.  [Chronic pelvic pain in women from a gynecologic viewpoint].

Authors:  F Siedentopf
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

Review 2.  Pelvic pain: a chronic visceral pain syndrome.

Authors:  U Wesselmann; P P Czakanski
Journal:  Curr Pain Headache Rep       Date:  2001-02

Review 3.  New developments in the pharmacotherapy of neuropathic chronic pelvic pain.

Authors:  Erin T Carey; Sawsan As-Sanie
Journal:  Future Sci OA       Date:  2016-10-05

4.  Antidepressant drugs for chronic urological pelvic pain: an evidence-based review.

Authors:  Christos Papandreou; Petros Skapinakis; Dimitrios Giannakis; Nikolaos Sofikitis; Venetsanos Mavreas
Journal:  Adv Urol       Date:  2010-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.